We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Case Report/Case Series |

Effect of Quadrivalent Human Papillomavirus Vaccination on Oral Squamous Cell Papillomas

Nika Cyrus, MD1; Adam B. Blechman, MD2; Matthew Leboeuf, MD3; Elizaveta A. Belyaeva, MD4; Maurits N. C. de Koning, PhD5; Koen D. Quint, MD, PhD5,6; John J. Stern, MD7
[+] Author Affiliations
1Department of Dermatology, University of Texas Southwestern Medical Center, Dallas
2Department of Dermatology, University of Virginia Health System, Charlottesville
3Department of Dermatology, University of Pennsylvania Health System, Philadelphia
4Department of Pathology, Pennsylvania Hospital, Philadelphia
5DDL Diagnostic Laboratory BV, Rijswijk, the Netherlands
6Department of Dermatology, Leiden University Medical Center, Leiden, the Netherlands
7Division of Infectious Diseases, Pennsylvania Hospital, University of Pennsylvania Health System, Philadelphia
JAMA Dermatol. 2015;151(12):1359-1363. doi:10.1001/jamadermatol.2015.2805.
Text Size: A A A
Published online


Importance  Cutaneous verruca vulgaris lesions (warts) and oral squamous cell papillomas are common lesions caused by human papillomavirus (HPV). Multiple reports have described cases of wart resolution following quadrivalent HPV vaccination. We report the case of a patient with chronic oral papillomas with resolution after quadrivalent HPV vaccination and perform a review of the literature.

Observations  An immunocompetent man in his 60s presented with chronic verrucous papules on the lips, tongue, and buccal mucosa refractory to multiple excisions. Biopsy showed squamous cell papilloma, and DNA sequencing revealed HPV-32. He received the quadrivalent HPV vaccine resulting in clearance of all lesions after 3 months. We found 8 reported cases of disseminated, recurrent warts with resolution after quadrivalent HPV vaccination. Improvement was seen within 4 weeks of vaccination, and resolution after 3 to 8 months.

Conclusions and Relevance  We report the case of recurrent oral papillomas caused by HPV-32 with complete resolution after quadrivalent HPV vaccination and reviewed reports of resolution of recalcitrant and disseminated warts after vaccination. Production of cross-protective immunoglobulins and cytotoxic T cells is a possible mechanism. There remains a critical need for randomized clinical trials to assess efficacy of quadrivalent HPV vaccination for treatment of oral squamous papillomas and cutaneous verruca vulgaris.

Figures in this Article


Place holder to copy figure label and caption
Figure 1.
Clinical Views of Lesions on Left Buccal Mucosa and Tongue Before and After Quadrivalent HPV Vaccination

HPV indicates human papillomavirus. A, Verrucous oral squamous cell papilloma papules, coalescing in some areas, on the left buccal mucosa before quadrivalent HPV vaccination. B, Complete resolution of lesions on the left buccal mucosa after vaccination.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Histopathologic Findings of Excisional Biopsy Specimens From Oral Squamous Cell Papillomas on the Left Buccal Mucosa (Hematoxylin-Eosin)

A, Moderately keratinized exophytic epithelial fronds supported on connective tissue, consistent with mucosal squamous cell papilloma (original magnification ×100). B, Dark nuclei with perinuclear haloes representing koilocytes are human papillomavirus (HPV)-infected cells; infiltrating lymphocytes and neutrophils are also seen (original magnification ×200). C, Three discrete areas of cells (outlined areas; original magnification not reported) were excised from the slide by laser-capture microdissection (LCM) and analyzed for HPV type as described in the HPV Typing subsection, with results summarized herein.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections